Adina Vultur
- Molecular Biology top 5%
- Oncology top 2%
- Cancer Research top 5%
- Immunology top 10%
- Cell Biology top 5%
- Co-authors
- Meenhard HerlynPhyllis A. GimottyAlexander RoeschMizuho Fukunaga‐KalabisThomas VogtJessie VillanuevaPatricia BraffordSusan E. Zabierowski
- Topics
- Melanoma and MAPK Pathways (14 papers)PI3K/AKT/mTOR signaling in cancer (9 papers)Cytokine Signaling Pathways and Interactions (8 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Adina Vultur
48 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Molecular Biology 2.1k
- Oncology 1.3k
- Cancer Research 556
- Immunology 374
- Cell Biology 332
Countries citing papers authored by Adina Vultur
This map shows the geographic impact of Adina Vultur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adina Vultur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adina Vultur more than expected).
Fields of papers citing papers by Adina Vultur
This network shows the impact of papers produced by Adina Vultur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adina Vultur. The network helps show where Adina Vultur may publish in the future.
Co-authorship network of co-authors of Adina Vultur
This figure shows the co-authorship network connecting the top 25 collaborators of Adina Vultur. A scholar is included among the top collaborators of Adina Vultur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adina Vultur. Adina Vultur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 85 | |
| 2 | 2 | |
| 3 | 127 | |
| 4 | 79 | |
| 5 | 73 | |
| 6 | 18 | |
| 7 | 72 | |
| 8 | 20 | |
| 9 | 7 | |
| 10 | A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growthbreakdown → | 872 |
| 11 | 43 | |
| 12 | 15 | |
| 13 | SKI-606, a novel Src kinase inhibitor, blocks migration and invasion of human breast cancer cells | 1 |
| 14 | 45 | |
| 15 | 89 | |
| 16 | 7 | |
| 17 | 5 | |
| 18 | 11 | |
| 19 | 67 | |
| 20 | 11 |
About Adina Vultur
Adina Vultur is a scholar working on Oncology, Molecular Biology and Immunology and Allergy, having authored 48 papers that have together received 3.0k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (14 papers), PI3K/AKT/mTOR signaling in cancer (9 papers) and Cytokine Signaling Pathways and Interactions (8 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (556 citations) and Molecular Biology (2.1k citations). Adina Vultur has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Meenhard Herlyn, Phyllis A. Gimotty, Alexander Roesch, Mizuho Fukunaga‐Kalabis, Thomas Vogt, Jessie Villanueva, Patricia Brafford, Susan E. Zabierowski, Devraj Basu and Richard Jove. Their work appears in journals such as Cell, Journal of Biological Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.